cagri semaglutide Coadministered Cagrilintide and in Adults with Overweight or Obesity 1 CagriSema 2.4 mg /

1st Edition

Multiplexed libraries were sequenced as 50 bp single-end reads on the Illumina NextSeq system (VBCF)

That means the same active molecule, the same dosing, the same clinical performance

Cagrilintide: Long-acting amylin analog explained What cagrilintide is: Synthetic analog of human amylin hormone Also called "pramlintide long-acting" (related compound) Developed by Novo Nordisk Currently investigational (Phase 3 trials) Not yet FDA approved (as of 2024) Weekly subcutaneous injection Natural amylin background: Peptide hormone co-secreted with insulin Made by pancreatic beta cells Released after meals in response to nutrients Important satiety signal Regulates postprandial glucose Deficient in diabetes Why synthetic cagrilintide was developed: Natural amylin very short half-life (minutes) Impractical for treatment Cagrilintide engineered for long duration Weekly dosing vs multiple daily injections Better pharmacokinetics Enhanced stability Learn about peptides , how peptides work , and what are peptides used for at SeekPeptides

During follow-up, the patient described paresthesia on the left side and noted similar sensations extending to his right thumb